Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2025-12-25 @ 11:31 PM
Study NCT ID:
NCT00440193
Status:
COMPLETED
Last Update Posted:
2014-02-27
First Post:
2007-02-23
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03
Start Date Type:
None
Primary Completion Date:
2010-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-04
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-23
First Submit QC Date:
None
Study First Post Date:
2007-02-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-11-22
Results First Submit QC Date:
None
Results First Post Date:
2013-01-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-12-22
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-01-26
Last Update Post Date:
2014-02-27
Last Update Post Date Type:
ESTIMATED